Cargando…

A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study

BACKGROUND: Pancreatic head adenocarcinoma (PHAC), a malignant tumour, has a very poor prognosis, and the existing prognostic tools lack good predictive power. This study aimed to develop a better nomogram to predict overall survival after resection of non-metastatic PHAC. METHODS: Patients with non...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Wenbo, Wang, Zizheng, Wang, Fei, Zhang, Gong, Liu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106852/
https://www.ncbi.nlm.nih.gov/pubmed/33964898
http://dx.doi.org/10.1186/s12885-021-08250-4
_version_ 1783689844934836224
author Zou, Wenbo
Wang, Zizheng
Wang, Fei
Zhang, Gong
Liu, Rong
author_facet Zou, Wenbo
Wang, Zizheng
Wang, Fei
Zhang, Gong
Liu, Rong
author_sort Zou, Wenbo
collection PubMed
description BACKGROUND: Pancreatic head adenocarcinoma (PHAC), a malignant tumour, has a very poor prognosis, and the existing prognostic tools lack good predictive power. This study aimed to develop a better nomogram to predict overall survival after resection of non-metastatic PHAC. METHODS: Patients with non-metastatic PHAC were collected from the Surveillance, Epidemiology, and End Results (SEER) database and divided randomly into training and validation cohorts at a ratio of 7:3. Cox regression analysis was used to screen prognostic factors and construct the nomogram. Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated to evaluate the performance of the model. The predictive accuracy and clinical benefits of the nomogram were validated using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). RESULTS: From 2010 to 2016, 6419 patients with non-metastatic PHAC who underwent surgery were collected from the SEER database. A model including T stage, N stage, grade, radiotherapy, and chemotherapy was constructed. The concordance index of the nomogram was 0.676, and the AUCs of the model assessing survival at multiple timepoints within 60 months were significantly higher than those of the American Joint Committee on Cancer (AJCC) 8th staging system in the training cohort. Calibration curves showed that the nomogram had ability to predict the actual survival. The NRI, IDI, and DCA curves also indicated that our nomogram had higher predictive capability and clinical utility than the AJCC staging system. CONCLUSIONS: Our nomogram has an ability to predict overall survival after resection of non-metastatic PHAC and includes prognostic factors that are easy to obtain in clinical practice. It would help assist clinicians to conduct personalized medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08250-4.
format Online
Article
Text
id pubmed-8106852
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81068522021-05-10 A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study Zou, Wenbo Wang, Zizheng Wang, Fei Zhang, Gong Liu, Rong BMC Cancer Research BACKGROUND: Pancreatic head adenocarcinoma (PHAC), a malignant tumour, has a very poor prognosis, and the existing prognostic tools lack good predictive power. This study aimed to develop a better nomogram to predict overall survival after resection of non-metastatic PHAC. METHODS: Patients with non-metastatic PHAC were collected from the Surveillance, Epidemiology, and End Results (SEER) database and divided randomly into training and validation cohorts at a ratio of 7:3. Cox regression analysis was used to screen prognostic factors and construct the nomogram. Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated to evaluate the performance of the model. The predictive accuracy and clinical benefits of the nomogram were validated using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). RESULTS: From 2010 to 2016, 6419 patients with non-metastatic PHAC who underwent surgery were collected from the SEER database. A model including T stage, N stage, grade, radiotherapy, and chemotherapy was constructed. The concordance index of the nomogram was 0.676, and the AUCs of the model assessing survival at multiple timepoints within 60 months were significantly higher than those of the American Joint Committee on Cancer (AJCC) 8th staging system in the training cohort. Calibration curves showed that the nomogram had ability to predict the actual survival. The NRI, IDI, and DCA curves also indicated that our nomogram had higher predictive capability and clinical utility than the AJCC staging system. CONCLUSIONS: Our nomogram has an ability to predict overall survival after resection of non-metastatic PHAC and includes prognostic factors that are easy to obtain in clinical practice. It would help assist clinicians to conduct personalized medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08250-4. BioMed Central 2021-05-08 /pmc/articles/PMC8106852/ /pubmed/33964898 http://dx.doi.org/10.1186/s12885-021-08250-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zou, Wenbo
Wang, Zizheng
Wang, Fei
Zhang, Gong
Liu, Rong
A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
title A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
title_full A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
title_fullStr A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
title_full_unstemmed A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
title_short A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
title_sort nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106852/
https://www.ncbi.nlm.nih.gov/pubmed/33964898
http://dx.doi.org/10.1186/s12885-021-08250-4
work_keys_str_mv AT zouwenbo anomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT wangzizheng anomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT wangfei anomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT zhanggong anomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT liurong anomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT zouwenbo nomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT wangzizheng nomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT wangfei nomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT zhanggong nomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy
AT liurong nomogrampredictingoverallsurvivalinpatientswithnonmetastaticpancreaticheadadenocarcinomaaftersurgeryapopulationbasedstudy